Stavudine

Stavudine

SCHEMBL28086387

Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O.Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

pol

The experimentally established mechanism targets of Stavudine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALB P02768 4/20 0.64
LMNA P02545 3/20 0.64
CACNA1F O60840 2/20 0.64
MAPT P10636 2/20 0.64
CACNA1D Q01668 2/20 0.64
CACNA1S Q13698 2/20 0.64
CACNA1C Q13936 2/20 0.64
PDE3A Q14432 2/20 0.64
ALDH1A1 P00352 1/20 0.57
POLB P06746 1/20 0.57
ADRA1A P35348 1/20 0.57
BLM P54132 1/20 0.57
POLG P54098 1/20 0.45
BCHE P06276 8/20 0.39
TK2 O00142 1/20 0.39
TK1 P04183 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Stavudine SCHEMBL4773402 1.00 ALB (0.64) ALBLMNACACNA1FMAPTCACNA1D
Didanosine SCHEMBL23925471 0.86 ALB (0.50) ALBLMNACACNA1FMAPTCACNA1D
Stavudine SCHEMBL4405002 0.86 ALB (0.66) ALBLMNACACNA1FMAPTCACNA1D
Lamivudine SCHEMBL22364335 0.86 ALB (0.65) ALBLMNACACNA1FMAPTCACNA1D
Stavudine SCHEMBL7053412 0.86 LMNA (0.60) ALBLMNACACNA1FMAPTCACNA1D
Stavudine SCHEMBL8185422 0.86 LMNA (0.60) ALBLMNACACNA1FMAPTCACNA1D
Nevirapine SCHEMBL1898785 0.83 LMNA (0.46) ALBLMNACACNA1FMAPTCACNA1D
Nevirapine SCHEMBL29379693 0.83 LMNA (0.46) ALBLMNACACNA1FMAPTCACNA1D
Lamivudine SCHEMBL465678 0.80 ALB (1.00) ALBLMNACACNA1FMAPTCACNA1D
Lamivudine SCHEMBL2422788 0.80 ALB (1.00) ALBLMNACACNA1FMAPTCACNA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103717597-B Heterocyclic compounds as kinase inhibitors 原真股份有限公司 2017-07-04 CN disclosed
CN-103492389-B Pyrazolo [4,3-d] pyrimidine as inhibitors of kinases 原真股份有限公司 2016-09-14 CN disclosed